Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers
Nature Medicine - United Kingdom
doi 10.1038/nm.1890
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2008
Authors
Publisher
Springer Science and Business Media LLC